...
机译:一线铂类化疗失败后的晚期小肠腺癌患者中的氟尿嘧啶,亚叶酸钙和伊立替康二线化疗(FOLFIRI方案)
Medical Oncology Service Hospital Saint Antoine AP-HP University of Paris VI Paris France;
Biostatistics and Epidemiology Unit Georges-François Leclerc Center Dijon France;
Department of Medicine Gustave Roussy Institute University of Paris South Villejuif France;
Hepatogastroenterology Service Meaux Hospital Center Meaux France;
Hepatogastroenterology Service Saint-Louis Hospital AP-HP Paris France;
Hepatogastroenterology Service Kremlin Bicetre Hospital AP-HP Kremlin Bicêtre France;
Hepatogastroenterology Service Charles Nicolle Hospital Rouen France;
Hepatogastroenterology Service Georges Pompidou European Hospital AP-HP Paris France;
Hepatogastroenterology Service Avicenne Hospital AP-HP University of Paris XIII Bobigny France;
Association des Gastroentérologues Oncologues (Gastroenterologists Oncologists Association) Paris France;
advanced small bowel adenocarcinoma; chemotherapy; second line; FOLFIRI; survival;
机译:一线铂类化疗失败后的晚期小肠腺癌患者接受氟尿嘧啶,亚叶酸钙和伊立替康二线化疗(FOLFIRI方案):一项多中心AGEO研究。
机译:比较二线改良EOX(依匹比星,奥沙利铂和卡培他滨)与伊立替康,5-氟尿嘧啶和亚叶酸(FOLFIRI)方案在转移性胃癌患者中的疗效,这些患者在一线改良多西紫杉醇和顺铂加氟尿嘧啶(DCF)的基础上进展养生
机译:6535一项对伊立替康,5-氟尿嘧啶和亚叶酸钙(FOLFIRI)进行的双周化学疗法在先前化疗失败的晚期胃癌患者(包括紫杉烷,氟嘧啶和铂)中进行的双周化学治疗的II期研究
机译:组合化疗与多西紫杉醇和伊替康的疗效,作为晚期胃癌的第一或二线治疗
机译:化学疗法治疗晚期视网膜母细胞瘤的临床比较:动脉内和玻璃体内化疗与动脉内和静脉内化疗
机译:伊立替康亚叶酸钙和5-氟尿嘧啶(改良的FOLFIRI)作为弱势或老年晚期胃癌患者的挽救性化疗
机译:5氟尿嘧啶,白杨素和伊替替康(Folfiri)作为转移性胃癌中的第三线化疗治疗,氟嘧啶失败后,铂,蒽环素和紫杉烷后